AMBER EDDY: Open Payments
NPI 1336845346 · ELIZABETHTOWN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 16 payments from 8 companies in 2025. Trend: 2023 $187 · 2024 $285 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $164 |
| Antares Pharma, Inc. | 2 | $59 |
| Lilly USA, LLC | 3 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| ABBVIE INC. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| TOLMAR, INC. | 1 | $20 |
Products named: Wegovy, XYOSTED, GEMTESA, VRAYLAR, BREZTRI, JARDIANCE, ZENPEP, LINZESS.
Industry payments across NC — which companies pay providers there.
